Can enzyme therapy calm an inflamed heart?
NCT ID NCT07235709
Summary
This study aims to see if a specific enzyme replacement therapy (agalsidase alfa) can reduce inflammation in the hearts of people with Fabry disease. Researchers will use detailed heart scans (PET-CMR) to measure inflammation in 25 patients before they start treatment and again after 12 months of therapy. The goal is to understand if this treatment helps control the heart complications of this rare genetic condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FABRY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine
RECRUITINGSeoul, 03722, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.